GSK
GSK plc
NYSE: GSK · London · Healthcare
$49.89-0.98 (-1.93%)Closed
Market Cap$215.30B
Cash—most recent
Runway—
P/E (TTM)—
52-Wk Range$38.17 – $59.60
Avg Volume4.6M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$49.89+25.3%
Pipeline

Drug candidates sponsored by GSK · ClinicalTrials.gov

69 drugs · 100 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 4Duac® Gel / Differin® Gel
Acne Vulgaris
Completed
2005-08past
1
Phase 4Clobetasol propionate foam
Psoriasis
Completed
2007-12past
1
Phase 4Duac Gel
Acne Vulgaris
Completed
2008-08past
1
Phase 4Benzoyl peroxide with clindamycin
Acne
Completed
2008-08past
1
Phase 4Epiduo Gel
Acne Vulgaris
Completed
2009-04-24past
1
Phase 4Olux-E Foam
Plaque-Type Psoriasis
Completed
2009-06past
1
Phase 4BENZOYL PEROXIDE/ CLINDAMYCIN
Acne Vulgaris
Completed
2009-06past
1
Phase 4Clindamycin and benzoyl peroxide
Acne Vulgaris
Completed
2009-08past
2
Phase 4MAXCLARITY II (2.5% BPO) Foam Cleanser
Acne Vulgaris
Completed
2009-11-20past
1
Phase 4Unnamed
Acne Vulgaris
Completed
2010-01-01past
1
Phase 4Acitretin (also called U0279)
Plaque Psoriasis
Withdrawn
2010-03past
1
Phase 4Ketoconazole
Dermatitis, Seborrheic
Completed
2010-04past
1
Phase 4Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene
Acne Vulgaris
Completed
2010-04past
1
Phase 40.25 % Miconazole Nitrate Ointment
Diaper Rash
Completed
2010-12past
1
Phase 4clobetasol propionate 0.05%
Dermatitis, Chronic
Completed
2011-03-01past
1
Phase 4Belimumab plus Early Vaccination
Systemic Lupus Erythematosus
Completed
2015-09-01past
1
Phase 4Placebo plus standard therapy
Systemic Lupus Erythematosus
Completed
2018-06-18past
1
Phase 2Liarozole
Ichthyosis, Lamellar
Completed
2007-04past
1
Phase 3Itraconazole 100mg capsules
Onychomycosis
Completed
2008-10past
1
Phase 3CT Gel
Acne Vulgaris+1 more
Completed
2009-04past
1
Phase 3CTGel/ BPO Wash
Acne Vulgaris
Completed
2009-06-01past
1
Phase 3Retpamulin Ointment, 1%
Skin Infections, Bacterial
Completed
2010-07past
1
Phase 3Tazarotene foam
Acne Vulgaris
Completed
2010-11past
3
Phase 3Calcipotriene Foam
Psoriasis
Completed
2010-12past
1
Phase 3alitretinoin
Eczema+1 more
Completed
2014-03-12past
2
Phase 3Belimumab 1 mg/kg
Systemic Lupus Erythematosus
Completed
2015-03past
1
Phase 3Dutasteride
Alopecia
Completed
2016-03-19past
1
Phase 3belimumab
Systemic Lupus Erythematosus+1 more
Completed
2016-12-09past
3
Phase 3Placebo
Systemic Lupus Erythematosus+3 more
Completed
2017-02-06past
4
Phase 3Momelotinib
Primary Myelofibrosis (PMF)+9 more
Completed
2017-04-10past
6
Phase 3BLU-5937
Cough+4 more
Active, not recruiting
2026-06-10past
5
Phase 33APS
Alzheimer Disease+1 more
Unknown—2
Phase 3Tramiprosate (3APS)
Alzheimer's Disease
Unknown—1
Phase 2NC-503 (Anti-amyloidotic (AA) Agent)
Secondary (AA) Amyloidosis+5 more
Completed—1
Phase 2Talarozole
Psoriasis+1 more
Completed
2007-05-01past
3
Phase 2Benzoyl peroxide gel
Acne Vulgaris
Completed
2009-03past
1
Phase 2NC-503 (eprodisate disodium)
Diabetes Mellitus, Type 2+1 more
Completed
2010-01past
1
Phase 2Albaconazole 100mg
Onychomycosis
Completed
2010-02-19past
1
Phase 2SRT2104
Diabetes Mellitus, Type 2+1 more
Completed
2010-09-18past
2
Phase 25.0g SRT501
Multiple Myeloma
Terminated
2010-11-04past
1
Phase 1CYT387
Primary Myelofibrosis+2 more
Completed
2012-04past
1
Phase 1Mapatumumab
Carcinoma, Hepatocellular+1 more
Completed
2013-05-31past
2
Phase 2PNT2258
Richter's Transformation+6 more
Completed
2016-08past
4
Phase 2Umeclidinium
Hyperhidrosis
Completed
2016-12-08past
1
Phase 2MMB
Primary Myelofibrosis (PMF)+2 more
Completed
2017-07-18past
1
Phase 1SRA737
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Completed
2019-10-28past
1
Phase 1Itraconazole
Healthy
Completed
2008-07past
1
Phase 1W0027
Tinea Pedis
Completed
2008-08past
1
Phase 1CT Gel (clindamycin 1% and tretinoin 0.025%)
Acne Vulgaris
Completed
2008-12-19past
1
Phase 1250 mg SRT2104 Suspension
Diabetes Mellitus, Type 2
Completed
2008-12-22past
1
Phase 10.5g SRT2104
Diabetes Mellitus, Type 2
Completed
2009-03-27past
1
Phase 1Albaconozole
Onychomycosis
Completed
2009-12-04past
1
Phase 1Albaconazole tablet 400mg
Onychomycosis
Completed
2010-01-20past
1
Phase 1Tazarotene Foam without irradiation
Acne Vulgaris
Completed
2010-04-10past
1
Phase 1Clindamycin 1%-Benzoyl Peroxide (BPO) 3% Gel,
Acne Vulgaris
Completed
2010-06-12past
1
Phase 1Tazarotene (Patch application in Challenge Phase)
Acne Vulgaris
Completed
2010-06-26past
1
Phase 1SRT3025
Diabetes Mellitus, Type 2
Completed
2011-11-24past
1
Phase 1SRT2379
Sepsis
Completed
2011-12-12past
2
Phase 1Cap SRT2104
Psoriasis
Completed
2012-12-05past
1
Phase 1HGS1036 + Paclitaxel + Carboplatin
Cancer
Suspended
2014-06past
1
Phase 1GSK2894512 cream
Psoriasis
Completed
2014-07-02past
1
Phase 1S. sonnei 1790GAHB
Shigellosis
Completed
2015-04past
2
Phase 1Combination therapy GSK2894512 Cream A + GSK2894512 Cream B
Dermatitis, Atopic
Completed
2015-09-24past
1
Phase 1Momelotinib (MMB)
Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer+2 more
Terminated
2017-03-08past
3
Phase 1BLU-5937 IR
Cough+1 more
Completed
2024-05-02past
1
Phase 1GSK5464714- Camlipixant
Cough
Completed
2024-08-22past
1
Phase 1Camlipixant
Cough+1 more
Completed
2024-12-17past
2
Phase 1IDRX-42
Gastrointestinal Neoplasms+4 more
Active, not recruiting
2027-03-10
1
N/AUnnamed
Acne Vulgaris
Completed
2011-12-01past
1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for GSK. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.